Previous Close | 108.85 |
1-Year Change | 20.9% |
6-Months Change | 26.56% |
3-Months Change | 22.52% |
Moving Avg (50d) | 93.98 |
Moving Avg (200d) | 85.97 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 5.15B |
Beta (3-Years) | 0.96 |
Revenue Growth (ttm) | 770.57% |
Net Profit Margin (ttm) | -90.33% |
Return On Assets (ttm) | -33.59% |
EPS (ttm) | -4.55 |
PE Ratio (ttm) | -23.92 |
Dividend Yield | % |
Asset Description: | Axsome Therapeutics, Inc. |
Predicted Direction: | Buy |
Signal Strength: | Neutral |
Forecast Date: | 2025-01-15 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
106.673 | 103.407 | 101.23 | 97.965 | 92.522 | 87.08 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.